Related Experiment Video
Updated: Aug 5, 2026

Investigating Intestinal Inflammation in DSS-induced Model of IBD
Published on: February 1, 2012
Relationship of common laboratory parameters to the activity of Crohn's disease in children
J S Hyams1, F Mandel, G D Ferry
1Division of Pediatric Gastroenterology & Nutrition, Harford Hospital, CT 06115.
Insights
Laboratory tests in the Pediatric Crohn's Disease Activity Index (PCDAI) generally correlate with disease severity in pediatric Crohn's patients. However, no single lab test accurately reflects disease activity in all children.
Area of Science:
- Pediatric Gastroenterology
- Inflammatory Bowel Disease Research
- Clinical Diagnostics
Background:
- The Pediatric Crohn's Disease Activity Index (PCDAI) is used to assess disease severity in children.
- PCDAI incorporates symptoms, physical exams, nutrition, and laboratory tests (hematocrit, ESR, albumin).
Purpose of the Study:
- To evaluate the relationship between individual laboratory parameters and disease activity indices in pediatric Crohn's disease.
- To determine the utility of common lab tests in assessing disease severity across different disease locations.
Main Methods:
- Analysis of clinical and laboratory data from 133 pediatric patients across 12 North American centers.
- Statistical examination of correlations between hematocrit, ESR, albumin, PCDAI, modified Harvey-Bradshaw Index, and physician global assessment.
Main Results:
- All tested laboratory parameters showed a significant relationship with PCDAI in both small bowel and colonic disease.
- Laboratory tests correlated significantly with modified Harvey-Bradshaw Index and global assessment in small bowel disease.
- ESR and hematocrit showed significant correlations with disease activity measures in large bowel disease.
Conclusions:
- Laboratory tests within the PCDAI generally reflect disease activity in pediatric Crohn's patients.
- No single laboratory test is sufficient to assess disease activity in all pediatric Crohn's patients.
- Further research is needed to identify additional laboratory markers for comprehensive disease activity assessment.
Abstract:
The Pediatric Crohn's Disease Activity Index (PCDAI) has been proposed as a simple instrument to aid in the classification of patients by disease severity. The PCDAI includes subjective patient reporting of symptoms, physical examination, nutritional parameters, and several common laboratory tests (hematocrit, erythrocyte sedimentation rate, albumin). In this report we examine the relationship of each of the laboratory parameters to the PCDAI, as well as to a modified Harvey-Bradshaw Index score and physician global assessment of disease activity. Data were gathered from the clinical and laboratory observations from 133 children and adolescents at 12 pediatric gastroenterology centers in North America. A statistically significant relationship (p less than 0.05) was noted between each of the laboratory tests and the PCDAI for patients with either disease limited to the small bowel or in those with colonic involvement. For patients with disease limited to the small bowel, a statistically significant (p less than 0.05) relationship was also noted between the three laboratory parameters and the modified Harvey-Bradshaw Index and global assessment. For patients with large-bowel involvement, the erythrocyte sedimentation rate was statistically related to the modified Harvey-Bradshaw Index and global assessment (p less than 0.01), as was hematocrit to global assessment (p less than 0.01). Although the laboratory parameters used in the PCDAI appear to generally reflect disease activity in most patients, no single laboratory test is adequate to reflect disease activity in all patients. Future work will need to identify additional laboratory measures to reflect the inflammatory process and serve as important adjuncts in the assessment of disease activity.
Related Concept Videos
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Serum Laboratory Studies, Stool Test, Breath Test
Inflammatory Bowel Disease III: Crohn's Disease
Inflammatory Bowel Disease IV: Clinical Manifestations

